JAC Advance Access published online on October 25, 2007
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm410
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leading article |
Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis
1 Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Lisburn Road, Belfast BT9 7AD, Northern Ireland, UK 2 Department of Cardiology, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK
* Corresponding author. Tel: +44-28-9026-3554; Fax: +44-28-9026-3991; E-mail: jemoore{at}niphl.dnet.co.uk
Over the last decade, a novel methicillin-resistant Staphylococcus aureus (MRSA) has emerged, primarily associated with healthy individuals within the community. This organism is distinct from healthcare-associated MRSA (HA-MRSA) in terms of epidemiology, microbiology and clinical manifestation and as such has been defined as community-associated MRSA (CA-MRSA). Given that S. aureus is a major aetiological agent of infective endocarditis (IE), particularly associated with the iv drug user population, reports of IE attributed to CA-MRSA are now emerging in the literature. The aims of this article are to (i) define and contrast CA-MRSA with HA-MRSA; (ii) review the published cases of CA-MRSA IE to date; and (iii) evaluate the current international recommendations for antibiotic prophylaxis and treatment regimens for IE in relation to CA-MRSA.
Key Words: community-acquired MRSA , PVL , Panton-Valentine leucocidin
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. I. Llarrull, J. F. Fisher, and S. Mobashery Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New {beta}-Lactams That Meet the Challenge Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4051 - 4063. [Full Text] [PDF] |
||||
![]() |
J. Meng, H. Wang, Z. Hou, T. Chen, J. Fu, X. Ma, G. He, X. Xue, M. Jia, and X. Luo Novel Anion Liposome-Encapsulated Antisense Oligonucleotide Restores Susceptibility of Methicillin-Resistant Staphylococcus aureus and Rescues Mice from Lethal Sepsis by Targeting mecA Antimicrob. Agents Chemother., July 1, 2009; 53(7): 2871 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dubois, C. Arpin, V. Dupart, A. Scavelli, L. Coulange, C. Andre, I. Fischer, F. Grobost, J.-P. Brochet, I. Lagrange, et al. {beta}-Lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres) J. Antimicrob. Chemother., August 1, 2008; 62(2): 316 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wolff, H. Hahne, M. Hecker, and D. Becher Complementary Analysis of the Vegetative Membrane Proteome of the Human Pathogen Staphylococcus aureus Mol. Cell. Proteomics, August 1, 2008; 7(8): 1460 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Tsai, Y.-S. Chen, S. S.-J. Lee, and Y.-C. Liu Comment on: Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis J. Antimicrob. Chemother., April 1, 2008; 61(4): 966 - 967. [Full Text] [PDF] |
||||
![]() |
B. C. Millar, B. D. Prendergast, and J. E. Moore Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis--authors' response J. Antimicrob. Chemother., April 1, 2008; 61(4): 967 - 968. [Full Text] [PDF] |
||||


